Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by biorunon Nov 22, 2023 2:00pm
137 Views
Post# 35748818

RE:Didn't age well - maybe it needs a shot of TFC-1067 or 1326

RE:Didn't age well - maybe it needs a shot of TFC-1067 or 1326Delusional is not a leadership strategy that I have ever seen in a management text book, but clear that it doesn't hold for very long as you have so nicely laid out.

Yes, they were quite pumped at the time of the deal. My educated guess on this one is that they thought the announcement should have driven them up to 80 cents or north and the world would be their oyster. But in what world does Howard think he can support that when they couldn't be permitted to say a thing about the terms of the deal? He knows ALL the terms of the deal, and he keeps buying more shares.

One way we are going to get screwed is from not knowing anything and counting on our terrible experiences on communication to make investment decisions, then all of a sudden baboom, we are trading sky high because whatever Howard is sitting on with that agreement actually comes to fruition, maybe with more certainty than ever, and meanwhile we are sitting back saying WTF?. Or maybe doesn't end that way and we keep dragging along. But he keeps buying more shares. Go figure. 


<< Previous
Bullboard Posts
Next >>